Literature DB >> 25696634

Pulmonary arterial hypertension associated with congenital heart disease: the efficacy of drug treatment in symptomatic patients.

I R Henkens, H W Vliegen.   

Abstract

Entities:  

Year:  2006        PMID： 25696634      PMCID： PMC2557262     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  2 in total

Review 1.  Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Vallerie V McLaughlin; Kenneth W Presberg; Ramona L Doyle; Steven H Abman; Douglas C McCrory; Terry Fortin; Gregory Ahearn
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

2.  Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.

Authors:  S C Apostolopoulou; A Manginas; D V Cokkinos; S Rammos
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.